Alimera Sciences, Inc.: meeting of 4 Sep 2024

Votes reported on Form N-PX, item by item

94 Form N-PX filers reported votes at the Alimera Sciences, Inc. meeting of 4 Sep 2024. Their records fall into 4 items below, in ballot order: management items first, then proposals from security holders. Each bar shows how the reporting filers split; it is not the result of the meeting.

foragainstabstain, withhold or otheramber tick: the portion cast against management

Items

SECTION 14A SAY-ON-PAY VOTESIssuer

Advisory vote on executive pay (say-on-pay)

126 vote records from 89 filers. 57 of the 87 filers that marked the item either way voted against management. 2 filers reported this item without a management mark.

33.7% for61.8% against4.5% other65.5% against management89 filers88.9% for10.1% against1.0% other11.1% against management40,777,533 reported shares

EXTRAORDINARY TRANSACTIONSIssuer

EXTRAORDINARY TRANSACTIONS: management items

Management items in this category are shown together; filers word and number them differently.

58 vote records from 33 filers. 0 of the 33 filers that marked the item either way voted against management.

100.0% for0.0% against0.0% against management33 filers99.3% for0.0% against0.7% other0.7% against management2,866,416 reported shares, counted once per item in this group

COMPENSATIONIssuer

COMPENSATION: management items

Management items in this category are shown together; filers word and number them differently.

3 vote records from 3 filers. 1 of the 3 filers that marked the item either way voted against management.

66.7% for33.3% against33.3% against management3 filers100.0% for0.0% against0.0% against management102,013 reported shares, counted once per item in this group

CORPORATE GOVERNANCEIssuer

CORPORATE GOVERNANCE: management items

Management items in this category are shown together; filers word and number them differently.

64 vote records from 36 filers. 8 of the 36 filers that marked the item either way voted against management.

77.8% for22.2% against22.2% against management36 filers78.4% for20.9% against0.7% other21.6% against management2,983,574 reported shares, counted once per item in this group

How the largest families voted

Family	1. Say-on-pay
Vanguard	Against *
BlackRock and iShares	For
Fidelity	Against *
State Street and SPDR	For
Invesco	Against *
Equitable	For
Charles Schwab	Against *
Nuveen and TIAA	Against *
ProShares and ProFunds	Against *
Morgan Stanley, Eaton Vance and Calvert	Against *
PGIM and Prudential	For
Northern Trust and FlexShares	Against *
SEI	Against *
T. Rowe Price	Against *
Lincoln Financial	For
Nationwide	Against *
Victory Capital	Against *
Guggenheim and Rydex	Against *
BNY Mellon	Against *
Principal	Against *
Pacific Life funds	For
Global X	Against *
AllianceBernstein	Against *
DWS	Against *
Neuberger Berman	For

* against management. A family's position is the way most of its reported shares were voted across its filers; "split" means no single position led. "No report" means none of the family's filers listed the item.

Questions

How did large funds vote at the Alimera Sciences, Inc. meeting?

94 Form N-PX filers reported votes at the meeting of 4 Sep 2024. On say-on-pay, 57 of 87 voted against management (65.5%). The family table lists each of the largest families item by item.

Is this the meeting result?

No. These are the votes of funds and managers that file Form N-PX, counted by filer and by the shares they reported. The certified result, which includes every shareholder, is reported by Alimera Sciences, Inc. on Form 8-K.

Why are director elections shown as counts only?

Director records name the nominee. This site does not publish pages or rows about individuals, so for director elections it keeps the number of nominees and the split of votes and discards the wording.

Every meeting on file for Alimera Sciences, Inc.

Provenance: SEC EDGAR, Form N-PX and N-PX/A filings listing Alimera Sciences, Inc. with a meeting date within three days of 4 Sep 2024. Proposal titles are the most common wording among filers and are replaced by the SEC category where a wording could name a person. Not verified by the SEC. Filings read through 30 Sep 2026.